{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:22:51Z","timestamp":1794604971333,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ahjo.2026.100937","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:17:14Z","timestamp":1791389834000},"page":"100937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Proteomic markers associated with blood pressure, hypertension, and treatment-resistant hypertension"],"prefix":"10.1016","volume":"71","author":[{"given":"Anna","family":"Dieden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manan","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"R\u00e5stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Lindblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bledar","family":"Daka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margr\u00e9t","family":"Le\u00f3sd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amra","family":"Jujic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10226","key":"10.1016\/j.ahjo.2026.100937_bb0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ahjo.2026.100937_bb0010","series-title":"Hypertension","author":"Organisation WH","year":"2023"},{"issue":"9","key":"10.1016\/j.ahjo.2026.100937_bb0015","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ahjo.2026.100937_bb0020","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ahjo.2026.100937_bb0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jash.2014.03.003","article-title":"Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality","volume":"8","author":"Irvin","year":"2014","journal-title":"J. Am. Soc. Hypertens."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100937_bb0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41440-022-00885-5","article-title":"Application of omics in hypertension and resistant hypertension","volume":"45","author":"Guo","year":"2022","journal-title":"Hypertens. Res."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100937_bb0035","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/CIRCRESAHA.118.311342","article-title":"Omics of blood pressure and hypertension","volume":"122","author":"Arnett","year":"2018","journal-title":"Circ. Res."},{"issue":"20","key":"10.1016\/j.ahjo.2026.100937_bb0040","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025936","article-title":"Exploring biomarkers associated with deteriorating vascular health using a targeted proteomics chip: the SABPA study","volume":"100","author":"Dieden","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ahjo.2026.100937_bb0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/HYPERTENSIONAHA.116.08906","article-title":"Proteomic-biostatistic integrated approach for finding the underlying molecular determinants of hypertension in human plasma","volume":"70","author":"Gajjala","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ahjo.2026.100937_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6761549","article-title":"Quantitative serum proteomic analysis of essential hypertension using iTRAQ technique","volume":"2017","author":"Xu","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100937_bb0055","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s12265-024-10541-7","article-title":"Plasma biomarker screening based on proteomic signature of patients with resistant hypertension","volume":"17","author":"Du","year":"2024","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100937_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101585","article-title":"Proteomic analysis of longitudinal changes in blood pressure","volume":"8","author":"Lin","year":"2019","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100937_bb0065","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/HYPERTENSIONAHA.123.22614","article-title":"Associations of proteomics with hypertension and systolic blood pressure: KORA S4\/F4\/FF4 and KORA Age1\/Age2 cohort studies","volume":"81","author":"Lin","year":"2024","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ahjo.2026.100937_bb0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41569-023-00964-1","article-title":"Immune and inflammatory mechanisms in hypertension","volume":"21","author":"Guzik","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100937_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ahj.2009.12.028","article-title":"Myocardial structure and function by echocardiography in relation to glucometabolic status in elderly subjects from 2 population-based cohorts: a cross-sectional study","volume":"159","author":"Leosdottir","year":"2010","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100937_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-2796.2000.00568.x","article-title":"Long-term outcome of the Malmo preventive project: mortality and cardiovascular morbidity","volume":"247","author":"Berglund","year":"2000","journal-title":"J. Intern. Med."},{"issue":"1906","key":"10.1016\/j.ahjo.2026.100937_bb0085","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1098\/rsta.2009.0127","article-title":"Selective inference in complex research","volume":"367","author":"Benjamini","year":"2009","journal-title":"Philos. Trans. R. Soc. A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.ahjo.2026.100937_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.804641","article-title":"Negative regulation of the IL-1 system by IL-1R2 and IL-1R8: relevance in pathophysiology and disease","volume":"13","author":"Supino","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100937_bb0095","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cmet.2015.11.013","article-title":"Interleukin-1 receptor activation potentiates salt reabsorption in angiotensin II-induced hypertension via the NKCC2 co-transporter in the nephron","volume":"23","author":"Zhang","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.ahjo.2026.100937_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phrs.2016.12.015","article-title":"Anakinra reduces blood pressure and renal fibrosis in one kidney\/DOCA\/salt-induced hypertension","volume":"116","author":"Ling","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.ahjo.2026.100937_bb0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2459\/JCM.0b013e32835dbcc8","article-title":"Gene expression in peripheral blood of patients with hypertension and patients with type 2 diabetes","volume":"15","author":"Stoynev","year":"2014","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.ahjo.2026.100937_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1293170","article-title":"Relationships among gut microbes, the interleukin family, and hypertension: a mediation Mendelian randomization study","volume":"10","author":"Zhao","year":"2023","journal-title":"Front. Nutr."},{"issue":"12","key":"10.1016\/j.ahjo.2026.100937_bb0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100937_bb0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13642","article-title":"Effects of interleukin-1beta inhibition on blood pressure, incident hypertension, and residual inflammatory risk: a secondary analysis of CANTOS","volume":"75","author":"Rothman","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ahjo.2026.100937_bb0125","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/HYPERTENSIONAHA.119.13982","article-title":"IL (interleukin)-1 receptor antagonist increases Ang (angiotensin [1-7]) and decreases blood pressure in obese individuals","volume":"75","author":"Urwyler","year":"2020","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100937_bb0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/eurheartj\/ehaf725","article-title":"Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study","volume":"47","author":"Meena","year":"2026","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100937_bb0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10741-007-9061-y","article-title":"Aminopeptidase N in arterial hypertension","volume":"13","author":"Danziger","year":"2008","journal-title":"Heart Fail. Rev."},{"issue":"38","key":"10.1016\/j.ahjo.2026.100937_bb0140","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.2174\/15672050113109990205","article-title":"Circulating aminopeptidase activities in men and women with essential hypertension","volume":"20","author":"Sanchez-Agesta Ortega","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100937_bb0145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4049\/jimmunol.1801276","article-title":"Angiogenic and arthritogenic properties of the soluble form of CD13","volume":"203","author":"Du","year":"2019","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100937_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00011-006-0076-y","article-title":"YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis","volume":"55","author":"Rathcke","year":"2006","journal-title":"Inflamm. Res."},{"issue":"11","key":"10.1016\/j.ahjo.2026.100937_bb0155","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004534","article-title":"YKL-40 level and hypertension incidence: a population-based nested case-control study in China","volume":"5","author":"Xu","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ahjo.2026.100937_bb0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cca.2017.08.003","article-title":"YKL-40 is a novel biomarker for predicting hypertension incidence among prehypertensive subjects: a population-based nested case-control study in China","volume":"472","author":"Xu","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ahjo.2026.100937_bb0165","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jcmm.16148","article-title":"Association of CHI3L1 gene variants with YKL-40 levels and hypertension incidence: a population-based nested case-control study in China","volume":"25","author":"Xu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100937_bb0170","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/resp.12283","article-title":"Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension","volume":"19","author":"Chen","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.ahjo.2026.100937_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.sleep.2016.08.001","article-title":"Chitinase-3-like protein-1 (YKL-40) as a marker of endothelial dysfunction in obstructive sleep apnea","volume":"25","author":"Jafari","year":"2016","journal-title":"Sleep Med."},{"key":"10.1016\/j.ahjo.2026.100937_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cophys.2020.09.016","article-title":"The role of inflammation in hypertension: novel concepts","volume":"19","author":"Patrick","year":"2021","journal-title":"Curr. Opin. Physio."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100937_bb0185","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/HYPERTENSIONAHA.111.185405","article-title":"Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension","volume":"59","author":"Muxfeldt","year":"2012","journal-title":"Hypertension"}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226002260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226002260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:01:41Z","timestamp":1794603701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226002260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"alternative-id":["S2666602226002260"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100937","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic markers associated with blood pressure, hypertension, and treatment-resistant hypertension","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100937"}}